Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Recurrent cervical cancer.

Leitao MM Jr, Chi DS.

Curr Treat Options Oncol. 2002 Apr;3(2):105-11. Review.

PMID:
12057073
2.

Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers.

Gemignani ML, Alektiar KM, Leitao M, Mychalczak B, Chi D, Venkatraman E, Barakat RR, Curtin JP.

Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):687-94.

PMID:
11395237
3.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM)..

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
4.

High dose rate intraoperative radiotherapy for recurrent cervical cancer and nodal disease.

Roth TM, Secord AA, Havrilesky LJ, Jones E, Clarke-Pearson DL.

Gynecol Oncol. 2003 Oct;91(1):258-60.

PMID:
14529691
5.

Radiotherapy for the treatment of locally recurrent cervical cancer.

Lanciano R.

J Natl Cancer Inst Monogr. 1996;(21):113-5. Review.

PMID:
9023839
6.

Indications for primary and secondary exenterations in patients with cervical cancer.

Marnitz S, Köhler C, Müller M, Behrens K, Hasenbein K, Schneider A.

Gynecol Oncol. 2006 Dec;103(3):1023-30. Epub 2006 Aug 4.

PMID:
16890276
7.

Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.

Hepel JT, Syed AM, Puthawala A, Sharma A, Frankel P.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1444-50.

PMID:
16029806
8.

Intraoperative radiotherapy in recurrent gynecological cancer.

Martínez Monge R, Jurado M, Azinovic I, Aristu JJ, Tangco E, Viera JC, Berián JM, Calvo FA.

Radiother Oncol. 1993 Aug;28(2):127-33.

PMID:
8248553
9.

Intraoperative radiation therapy in recurrent carcinoma of the uterine cervix: report of the French intraoperative group on 70 patients.

Mahé MA, Gérard JP, Dubois JB, Roussel A, Bussières E, Delannes M, Guillemin F, Schmitt T, Dargent D, Guillard Y, Martel P, Richaud P, Cuillière JC, De Ranieri J, Malissard L.

Int J Radiat Oncol Biol Phys. 1996 Jan 1;34(1):21-6.

PMID:
12118553
10.

Vaginal radiation brachytherapy to reduce central recurrence after radical hysterectomy for cervical carcinoma.

Photopulos GJ, Vander Zwaag R, Miller B, Bielskis W, Veerling PJ Jr.

Gynecol Oncol. 1990 Aug;38(2):187-90.

PMID:
2387534
11.

Total pelvic exenteration for primary and recurrent malignancies.

Ferenschild FT, Vermaas M, Verhoef C, Ansink AC, Kirkels WJ, Eggermont AM, de Wilt JH.

World J Surg. 2009 Jul;33(7):1502-8. doi: 10.1007/s00268-009-0066-7.

12.

Recurrent vulvar cancer.

Salom EM, Penalver M.

Curr Treat Options Oncol. 2002 Apr;3(2):143-53. Review.

PMID:
12057077
13.

Surgically (laparotomy/laparoscopy) guided placement of high dose rate interstitial irradiation catheters (LG-HDRT): technique and outcome.

Orr JW Jr, Dosoretz DD, Mahoney D, Roland PY, Kelly FJ, Blitzer P, Nakfoor B, Katin M, Rubenstein J, Boothby RR.

Gynecol Oncol. 2006 Jan;100(1):145-8. Epub 2005 Oct 24.

PMID:
16249021
14.

Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?

Backes FJ, Billingsley CC, Martin DD, Tierney BJ, Eisenhauer EL, Cohn DE, O'Malley DM, Salani R, Copeland LJ, Fowler JM.

Gynecol Oncol. 2014 Oct;135(1):95-9. doi: 10.1016/j.ygyno.2014.07.093. Epub 2014 Jul 30.

PMID:
25084510
15.
16.

The use of intraoperative radiation therapy in radical salvage for recurrent cervical cancer: outcome and toxicity.

Stelzer KJ, Koh WJ, Greer BE, Cain JM, Tamimi HK, Figge DC, Goff BA, Griffin TW.

Am J Obstet Gynecol. 1995 Jun;172(6):1881-6; discussion 1886-8.

PMID:
7778648
18.

Long-term experience in the surgical management of cancer of the uterine cervix.

Chi DS, Gemignani ML, Curtin JP, Hoskins WJ.

Semin Surg Oncol. 1999 Oct-Nov;17(3):161-7. Review.

PMID:
10504663
19.

High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina.

Beriwal S, Heron DE, Mogus R, Edwards RP, Kelley JL, Sukumvanich P.

Radiat Oncol. 2008 Feb 13;3:7. doi: 10.1186/1748-717X-3-7.

20.

Management of recurrent cervical cancer.

Dreyer G, Snyman LC, Mouton A, Lindeque BG.

Best Pract Res Clin Obstet Gynaecol. 2005 Aug;19(4):631-44. Epub 2005 Apr 9. Review.

PMID:
16150396

Supplemental Content

Support Center